Your browser doesn't support javascript.
loading
Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer.
Hoskin, Ashley J; Holt, Amy K; Legge, Danny N; Collard, Tracey J; Williams, Ann C; Vincent, Emma E.
Affiliation
  • Hoskin AJ; Department of Cellular and Molecular Medicine, Biomedical Sciences Building, University of Bristol, BS8 1TW Bristol, UK.
  • Holt AK; Department of Cellular and Molecular Medicine, Biomedical Sciences Building, University of Bristol, BS8 1TW Bristol, UK.
  • Legge DN; Department of Translational Health Sciences, Dorothy Hodgkin Building, University of Bristol, BS1 3NY Bristol, UK.
  • Collard TJ; Department of Cellular and Molecular Medicine, Biomedical Sciences Building, University of Bristol, BS8 1TW Bristol, UK.
  • Williams AC; Department of Cellular and Molecular Medicine, Biomedical Sciences Building, University of Bristol, BS8 1TW Bristol, UK.
  • Vincent EE; Department of Translational Health Sciences, Dorothy Hodgkin Building, University of Bristol, BS1 3NY Bristol, UK.
Explor Target Antitumor Ther ; 4(4): 600-615, 2023.
Article in En | MEDLINE | ID: mdl-37720350
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Explor Target Antitumor Ther Year: 2023 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Explor Target Antitumor Ther Year: 2023 Type: Article Affiliation country: United kingdom